Drug Type Allergen extract |
Synonyms Oralair Mites + [6] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (26 Mar 2015), |
RegulationOrphan Drug (South Korea) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Allergic asthma | Australia | 15 Apr 2016 | |
Rhinitis, Allergic, Perennial | Japan | 26 Mar 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaphylaxis | Phase 3 | Bulgaria | 14 Nov 2023 | |
Anaphylaxis | Phase 3 | Romania | 14 Nov 2023 | |
Anaphylaxis | Phase 3 | Lithuania | 14 Nov 2023 | |
Anaphylaxis | Phase 3 | Latvia | 14 Nov 2023 | |
Anaphylaxis | Phase 3 | Germany | 14 Nov 2023 | |
allergic rhinitis due to dust mite | Preclinical | - | 20 Nov 2018 | |
House dust mite allergy | Preclinical | United States | 29 Sep 2015 | |
House dust mite allergy | Preclinical | France | 29 Sep 2015 | |
Rhinitis, Allergic, Perennial | Preclinical | United States | 29 Sep 2015 | |
Rhinitis, Allergic, Perennial | Preclinical | France | 29 Sep 2015 |
Phase 2/3 | 509 | fihvdrzauw(alrdqwxtel) = motrlljytb nftqjvlhem (tyihhvobzg, uttmrmgwpj - svyedrmymc) View more | - | 19 May 2016 | |||
fihvdrzauw(alrdqwxtel) = esprrtvqdz nftqjvlhem (tyihhvobzg, pzhlatyrti - dsvdpwcxpd) View more |